Such effects induced by rMBP-NAP are also TLR2-dependent as shown by the fact that co-administration of TLR2-blocking antibody and rMBP-NAP inhibited the anti-tumor activity elicited by rMBP-NAP [74]. The gene discussed is CTNNBL1; the disease is neoplasm.